Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,014 | 948 | 94.2% |
| Travel and Lodging | $973.35 | 5 | 4.4% |
| Unspecified | $218.94 | 2 | 1.0% |
| Education | $104.31 | 6 | 0.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $4,972 | 104 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,690 | 219 | $0 (2024) |
| ABIOMED | $2,149 | 68 | $0 (2024) |
| Boston Scientific Corporation | $1,153 | 52 | $0 (2024) |
| Amgen Inc. | $1,152 | 55 | $0 (2024) |
| PFIZER INC. | $1,086 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,026 | 58 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $990.28 | 61 | $0 (2024) |
| Inari Medical, Inc. | $851.48 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $743.49 | 40 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,078 | 77 | Novartis Pharmaceuticals Corporation ($376.09) |
| 2023 | $2,296 | 84 | Inari Medical, Inc. ($530.32) |
| 2022 | $2,244 | 104 | Novartis Pharmaceuticals Corporation ($444.92) |
| 2021 | $2,850 | 132 | Abbott Laboratories ($868.59) |
| 2020 | $1,638 | 97 | Abbott Laboratories ($310.06) |
| 2019 | $3,929 | 160 | Abbott Laboratories ($1,014) |
| 2018 | $4,603 | 159 | Abbott Laboratories ($2,087) |
| 2017 | $2,674 | 148 | Amgen Inc. ($391.82) |
All Payment Transactions
961 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Heart Failure | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.89 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/06/2024 | Abbott Laboratories | PRESSUREWIRE (Device) | Food and Beverage | In-kind items and services | $54.97 | General |
| Category: Vascular | ||||||
| 11/06/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Not Applicable | ||||||
| 10/30/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $180.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $133.21 | General |
| Category: Heart Failure | ||||||
| 10/25/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $212.78 | General |
| Category: Renal Denervation System | ||||||
| 10/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $43.28 | General |
| Category: VTE | ||||||
| 09/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $22.06 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Research Studies & Clinical Trials
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,950 | 3,159 | $1.0M | $263,889 |
| 2022 | 24 | 1,483 | 2,452 | $752,100 | $200,918 |
| 2021 | 13 | 1,132 | 1,620 | $546,600 | $148,691 |
| 2020 | 13 | 1,043 | 1,586 | $550,480 | $144,220 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 405 | $101,250 | $41,152 | 40.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 231 | 530 | $119,250 | $35,955 | 30.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 215 | 221 | $132,600 | $32,671 | 24.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 178 | 179 | $168,260 | $30,689 | 18.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 166 | 295 | $95,875 | $30,062 | 31.4% |
| 99493 | Follow-up psychiatric collaborative care management, subsequent calendar month, first 60 minutes | Office | 2023 | 32 | 121 | $61,831 | $15,020 | 24.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 220 | 226 | $50,850 | $13,231 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $35,700 | $11,843 | 33.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 53 | 221 | $49,283 | $10,511 | 21.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 74 | 209 | $35,530 | $9,021 | 25.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 20 | 20 | $35,000 | $8,095 | 23.1% |
| 99492 | Initial psychiatric collaborative care management, first calendar month, first 70 minutes | Office | 2023 | 35 | 35 | $17,955 | $4,715 | 26.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 20 | 40 | $14,000 | $3,838 | 27.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 220 | 269 | $21,520 | $3,305 | 15.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 16 | $16,000 | $3,136 | 19.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 27 | 89 | $12,015 | $3,102 | 25.8% |
| 99494 | Psychiatric collaborative care management per calendar month, each additional 30 minutes | Office | 2023 | 16 | 52 | $10,140 | $2,663 | 26.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 15 | 60 | $9,000 | $2,476 | 27.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 26 | 26 | $9,750 | $1,501 | 15.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 48 | 48 | $3,216 | $869.28 | 27.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 12 | 13 | $2,925 | $34.19 | 1.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 189 | 200 | $120,000 | $33,947 | 28.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 220 | 510 | $114,750 | $31,274 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 297 | $74,250 | $30,481 | 41.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 127 | 275 | $89,375 | $24,073 | 26.9% |
About Dr. Avinash Khitri, M.D
Dr. Avinash Khitri, M.D is a Internal Medicine healthcare provider based in Covina, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1326246018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Avinash Khitri, M.D has received a total of $22,311 in payments from pharmaceutical and medical device companies, with $2,078 received in 2024. These payments were reported across 961 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($21,014).
As a Medicare-enrolled provider, Khitri has provided services to 5,608 Medicare beneficiaries, totaling 8,817 services with total Medicare billing of $757,718. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Covina, CA
- Active Since 07/05/2007
- Last Updated 09/19/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1326246018
Products in Payments
- Impella (Device) $2,149
- ENTRESTO (Drug) $2,131
- ELIQUIS (Drug) $1,589
- Mitra Clip system (Device) $1,459
- LifeVest (Device) $990.28
- CardioMEMS HF System (Device) $877.23
- FLOWTRIEVER CATHETER, S (Device) $851.48
- XARELTO (Drug) $586.93
- Corlanor (Drug) $580.74
- LEQVIO (Drug) $548.51
- Xience Sierra Coronary Stent System (Device) $534.69
- FARXIGA (Drug) $512.10
- Repatha (Biological) $491.78
- PRALUENT (Drug) $482.61
- BRILINTA (Drug) $447.77
- Dragonfly OCT (Device) $357.15
- Confirm Rx (Device) $278.11
- Arcalyst (Drug) $247.37
- CARDIOMEMS (Device) $242.28
- VYNDAQEL (Drug) $241.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Covina
Dr. Anne Quismorio, Md, MD
Internal Medicine — Payments: $67,472
Tuong Ha, M.d, M.D
Internal Medicine — Payments: $42,614
Sami Hayek, Md, MD
Internal Medicine — Payments: $21,554
Mrs. Sheri Pham, Md, MD
Internal Medicine — Payments: $11,724
Emin Zargarian, Md, MD
Internal Medicine — Payments: $8,927
Dr. Sanjay Khedia, M.d, M.D
Internal Medicine — Payments: $8,115